SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human

Antibodies directed against CD22 have been used in radioimmunotherapy (RIT) clinical trials to treat patients with diffuse large B-cell lymphoma (DLBCL) with promising results. However, relevant preclinical models are needed to facilitate the evaluation and optimization of new protocols. Spontaneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Etienne, Floriane, Berthaud, Maxime, Nguyen, Frédérique, Bernardeau, Karine, Maurel, Catherine, Bodet-Milin, Caroline, Diab, Maya, Abadie, Jérôme, Gouilleux-Gruart, Valérie, Vidal, Aurélien, Bourgeois, Mickaël, Chouin, Nicolas, Ibisch, Catherine, Davodeau, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018706/
https://www.ncbi.nlm.nih.gov/pubmed/32117707
http://dx.doi.org/10.3389/fonc.2020.00020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018706/
https://www.ncbi.nlm.nih.gov/pubmed/32117707
http://dx.doi.org/10.3389/fonc.2020.00020

Ejemplares similares